Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoarthritis gene therapy.

C H Evans1, J N Gouze, E Gouze

  • 1Center for Molecular Orthopaedics, Harvard Medical School, MA 02115, USA.

Gene Therapy
|January 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Home delivery for chondrocytes.

Osteoarthritis and cartilage·2025
Same author

How to Cure Rhus Poisoning.

The Homoeopathic physician·2023
Same author

Enthesis: not the same in each localisation - a molecular, histological and biomechanical study.

European cells & materials·2022
Same author

Mechanical and strain behaviour of human Achilles tendon during in vitro testing to failure.

European cells & materials·2022
Same author

Reverse dynamisation: a modern perspective on Stephan Perren's strain theory.

European cells & materials·2021
Same author

Healing of sub-critical femoral osteotomies in mice is unaffected by tacrolimus and deletion of recombination activating gene 1.

European cells & materials·2021
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Gene therapy offers a promising treatment for osteoarthritis (OA), a leading cause of disability. Intra-articular gene transfer, particularly using interleukin-1 receptor antagonist (IL-1Ra), shows potential for cartilage protection and warrants clinical study.

Area of Science:

  • Orthopedics and Regenerative Medicine
  • Molecular and Cellular Biology
  • Biotechnology

Background:

  • Osteoarthritis (OA) is a major cause of disability, characterized by joint degeneration.
  • Current OA treatments are often ineffective and costly.
  • Intra-articular gene therapy presents a localized treatment strategy for OA.

Purpose of the Study:

  • To review strategies for treating osteoarthritis using gene therapy.
  • To explore the potential of intra-articular gene transfer to target joint tissues like synovium and cartilage.
  • To evaluate the role of interleukin-1 (IL-1) in OA pathogenesis and the therapeutic efficacy of IL-1 receptor antagonist (IL-1Ra) gene transfer.

Main Methods:

  • Review of experimental progress in gene transfer to OA-affected joints, focusing on synovium.

Related Experiment Videos

  • Investigation of gene products that enhance cartilage matrix synthesis or inhibit degradation.
  • Assessment of IL-1Ra gene transfer efficacy in experimental OA models and safety in human joints.

    • Main Results:

    • Gene transfer to the synovium is experimentally advanced, with various vectors and protocols.
    • IL-1 is implicated as a key mediator of cartilage loss in OA.
    • Therapeutic effects of IL-1Ra gene transfer have been confirmed in multiple OA models, with safe delivery to human joints.

    Conclusions:

    • Intra-articular IL-1Ra gene transfer is a viable therapeutic strategy for OA.
    • Clinical studies for intra-articular IL-1Ra gene transfer in OA are indicated and should be funded.
    • Recombinant adeno-associated virus vectors offer a promising combination of safety and in vivo delivery for OA gene therapy.